(Q90422192)
Statements
Behcet's-like syndrome following pembrolizumab: An immune-related adverse event associated with programmed death receptor-1 inhibitor therapy (English)
Chay Bae
Tabanor Joy-Ann
William Traverse
1078155219877219
scientific article published on 01 October 2019